Tag: MentalHealthDisorders

Breaking News Healthcare Investing News Market News The Market Buzz

Breaking News: Mydecine Innovations Group Inc. Announces NeuroPharm Inc. Commences PTSD Clinical Trial Initiative With Leading European Research Institute

financial buzz07/16/2020

4245

Mydecine Innovations Group Inc. (OTC: MYCOF) (CSE: MYCO), is pleased to announce that, further to its press release of July 14, 2020, its prospective acquisition target NeuroPharm Inc. (“NeuroPharm”),...

Breaking News Healthcare Investing News Market News

Breaking News: Mydecine Innovations Group Inc. Signs Definitive Agreement for Acquisition of NeuroPharm Inc. Positioned as a Leader in the Development of Psychedelic Treatments for the Betterment of Veterans

financial buzz07/14/202007/14/2020

2949

Mydecine Innovations Group Inc. (OTC: MYCOF) (CSE: MYCO), is pleased to announce that, further to its press release on June 10, 2020, it has entered into a definitive share...

Tag: MentalHealthDisorders

Breaking News: Mydecine Innovations Group Inc. Announces NeuroPharm Inc. Commences PTSD Clinical Trial Initiative With Leading European Research Institute

Breaking News: Mydecine Innovations Group Inc. Signs Definitive Agreement for Acquisition of NeuroPharm Inc. Positioned as a Leader in the Development of Psychedelic Treatments for the Betterment of Veterans

ABOUT US

Tweets